Artivion, Inc.
AORT
Cena:
Valuace
8
Růst
48
Zdraví
61
Akcionáři
Akcionáři společnosti
Insider trading
Akcionáři společnosti
| Držitel | Počet akcií | Podíl společnosti | Změna % | Váha pozice v portfoliu | Prvně nakoupeno |
|---|
Insider trading
| Jméno | Pozice | Typ transakce | Počet převedených akcií | Průměrná cena akcie | Datum | Počet držených akcií |
|---|---|---|---|---|---|---|
| SEMEDO ANTHONY B. | director | J-Other | 6325 | 0.00 | 4.6 2026 | 6325 |
| SEMEDO ANTHONY B. | director | J-Other | 6325 | 0.00 | 4.6 2026 | 40635 |
| ACKERMAN THOMAS F | director | A-Award | 7576 | 0.00 | 20.5 2026 | 157472 |
| BEVEVINO DANIEL J | director | A-Award | 7576 | 0.00 | 20.5 2026 | 157637 |
| Bullock James | director | A-Award | 7576 | 0.00 | 20.5 2026 | 76223 |
| Burbank Jeffrey H | director | A-Award | 7576 | 0.00 | 20.5 2026 | 61372 |
| Hoff Elizabeth A | director | A-Award | 7576 | 0.00 | 20.5 2026 | 34765 |
| Salveson Jon W | director | A-Award | 7576 | 0.00 | 20.5 2026 | 137416 |
| SEMEDO ANTHONY B. | director | A-Award | 7576 | 0.00 | 20.5 2026 | 46960 |
| Borgstrom Marna P | director | A-Award | 7576 | 0.00 | 20.5 2026 | 56664 |
| Borgstrom Marna P | director | A-Award | 7850 | 0.00 | 19.5 2026 | 56938 |
| Mackin James P | officer: President & CEO | S-Sale | 17887 | 37.78 | 4.3 2026 | 947275 |
| Mackin James P | officer: President & CEO | A-Award | 116948 | 0.00 | 4.3 2026 | 965162 |
| Berry Lance A | officer: EVP, COO, CFO & Treasurer | S-Sale | 6316 | 37.78 | 4.3 2026 | 210827 |
| Berry Lance A | officer: EVP, COO, CFO & Treasurer | A-Award | 40874 | 0.00 | 4.3 2026 | 217143 |
| Davis John E | officer: Chief Commercial Officer | S-Sale | 4573 | 37.78 | 4.3 2026 | 230794 |
| Davis John E | officer: Chief Commercial Officer | A-Award | 28845 | 0.00 | 4.3 2026 | 235367 |
| Stanton Marshall S. | officer: SVP, Clinical & MD Affair | S-Sale | 2149 | 37.78 | 4.3 2026 | 60097 |
| Stanton Marshall S. | officer: SVP, Clinical & MD Affair | A-Award | 21838 | 0.00 | 4.3 2026 | 62246 |
| Holloway Jean F | officer: SVP, General Counsel | S-Sale | 8962 | 38.00 | 4.3 2026 | 185095 |
| Holloway Jean F | officer: SVP, General Counsel | S-Sale | 3843 | 37.78 | 4.3 2026 | 194057 |
| Holloway Jean F | officer: SVP, General Counsel | A-Award | 27795 | 0.00 | 4.3 2026 | 197900 |
| Horton Amy | officer: VP, Chief Accounting Officer | S-Sale | 901 | 37.78 | 4.3 2026 | 139088 |
| Horton Amy | officer: VP, Chief Accounting Officer | A-Award | 7475 | 0.00 | 4.3 2026 | 139989 |
| Davis John E | officer: Chief Commercial Officer | S-Sale | 2784 | 38.02 | 3.3 2026 | 206522 |
| Berry Lance A | officer: EVP, COO, CFO & Treasurer | S-Sale | 5178 | 38.02 | 3.3 2026 | 176269 |
| Holloway Jean F | officer: SVP, General Counsel | S-Sale | 2183 | 38.02 | 3.3 2026 | 170105 |
| Mackin James P | officer: President & CEO | S-Sale | 14911 | 38.02 | 3.3 2026 | 848214 |
| Stanton Marshall S. | officer: SVP, Clinical & MD Affair | S-Sale | 1513 | 38.02 | 3.3 2026 | 40408 |
| Horton Amy | officer: VP, Chief Accounting Officer | S-Sale | 641 | 38.02 | 3.3 2026 | 132514 |
| Davis John E | officer: Chief Commercial Officer | S-Sale | 2075 | 35.69 | 25.2 2026 | 188868 |
| Davis John E | officer: Chief Commercial Officer | S-Sale | 3773 | 37.59 | 25.2 2026 | 190943 |
| Davis John E | officer: Chief Commercial Officer | A-Award | 20438 | 0.00 | 25.2 2026 | 209306 |
| Berry Lance A | officer: EVP, COO, CFO & Treasurer | S-Sale | 4485 | 35.69 | 25.2 2026 | 143965 |
| Berry Lance A | officer: EVP, COO, CFO & Treasurer | S-Sale | 4981 | 37.59 | 25.2 2026 | 148450 |
| Berry Lance A | officer: EVP, COO, CFO & Treasurer | A-Award | 37482 | 0.00 | 25.2 2026 | 181447 |
| Mackin James P | officer: President & CEO | S-Sale | 13936 | 35.69 | 25.2 2026 | 766095 |
| Mackin James P | officer: President & CEO | S-Sale | 20962 | 37.59 | 25.2 2026 | 780031 |
| Mackin James P | officer: President & CEO | A-Award | 97030 | 0.00 | 25.2 2026 | 863125 |
| Holloway Jean F | officer: SVP, General Counsel | S-Sale | 1668 | 35.69 | 25.2 2026 | 152203 |
| Holloway Jean F | officer: SVP, General Counsel | S-Sale | 3079 | 37.59 | 25.2 2026 | 153871 |
| Holloway Jean F | officer: SVP, General Counsel | A-Award | 20085 | 0.00 | 25.2 2026 | 172288 |
| Stanton Marshall S. | officer: SVP, Clinical & MD Affair | S-Sale | 1259 | 35.69 | 25.2 2026 | 41921 |
| Stanton Marshall S. | officer: SVP, Clinical & MD Affair | S-Sale | 2423 | 37.59 | 25.2 2026 | 43180 |
| Horton Amy | officer: VP, Chief Accounting Officer | S-Sale | 830 | 35.69 | 25.2 2026 | 127497 |
| Horton Amy | officer: VP, Chief Accounting Officer | S-Sale | 1731 | 37.59 | 25.2 2026 | 128327 |
| Horton Amy | officer: VP, Chief Accounting Officer | A-Award | 5658 | 0.00 | 25.2 2026 | 133155 |
| Holloway Jean F | officer | 0 | 0.00 | 28.1 2026 | 0 | |
| Davis John E | officer | 0 | 0.00 | 28.1 2026 | 0 | |
| Stanton Marshall S. | officer | 0 | 0.00 | 28.1 2026 | 0 | |
| Davis John E | officer: Chief Commercial Officer | S-Sale | 5000 | 45.11 | 17.12 2025 | 193842 |
| Horton Amy | officer: VP, Chief Accounting Officer | S-Sale | 4572 | 44.42 | 9.12 2025 | 130058 |
| Holloway Jean F | officer: SVP, General Counsel | S-Sale | 5267 | 45.30 | 4.12 2025 | 156093 |
| Holloway Jean F | officer: SVP, General Counsel | S-Sale | 2048 | 45.30 | 4.12 2025 | 161360 |
| Mackin James P | officer: President & CEO | M-Exempt | 30921 | 29.62 | 4.12 2025 | 0 |
| Mackin James P | officer: President & CEO | S-Sale | 30921 | 45.46 | 4.12 2025 | 800993 |
| Mackin James P | officer: President & CEO | M-Exempt | 30921 | 29.62 | 4.12 2025 | 831914 |
| Mackin James P | officer: President & CEO | M-Exempt | 30921 | 29.62 | 3.12 2025 | 0 |
| Mackin James P | officer: President & CEO | S-Sale | 30921 | 45.56 | 3.12 2025 | 800993 |
| Mackin James P | officer: President & CEO | M-Exempt | 30921 | 29.62 | 3.12 2025 | 831914 |
| Horton Amy | officer: VP, Chief Accounting Officer | G-Gift | 750 | 0.00 | 2.12 2025 | 134630 |
| Stanton Marshall S. | officer: SVP, Clinical & MD Affair | M-Exempt | 2033 | 18.44 | 24.11 2025 | 20301 |
| Stanton Marshall S. | officer: SVP, Clinical & MD Affair | M-Exempt | 1355 | 11.03 | 24.11 2025 | 27075 |
| Stanton Marshall S. | officer: SVP, Clinical & MD Affair | S-Sale | 1355 | 44.28 | 24.11 2025 | 44753 |
| Stanton Marshall S. | officer: SVP, Clinical & MD Affair | S-Sale | 11888 | 44.14 | 24.11 2025 | 44753 |
| Stanton Marshall S. | officer: SVP, Clinical & MD Affair | S-Sale | 2033 | 44.32 | 24.11 2025 | 44753 |
| Stanton Marshall S. | officer: SVP, Clinical & MD Affair | M-Exempt | 1355 | 11.03 | 24.11 2025 | 46108 |
| Stanton Marshall S. | officer: SVP, Clinical & MD Affair | M-Exempt | 2033 | 18.44 | 24.11 2025 | 46786 |
| Stanton Marshall S. | officer: SVP, Clinical & MD Affair | M-Exempt | 27075 | 11.03 | 24.11 2025 | 0 |
| Stanton Marshall S. | officer: SVP, Clinical & MD Affair | M-Exempt | 20301 | 18.44 | 24.11 2025 | 0 |
| Stanton Marshall S. | officer: SVP, Clinical & MD Affair | S-Sale | 5715 | 45.35 | 24.11 2025 | 44753 |
| Stanton Marshall S. | officer: SVP, Clinical & MD Affair | S-Sale | 8370 | 45.35 | 24.11 2025 | 44753 |
| Stanton Marshall S. | officer: SVP, Clinical & MD Affair | S-Sale | 14586 | 44.92 | 24.11 2025 | 50468 |
| Stanton Marshall S. | officer: SVP, Clinical & MD Affair | S-Sale | 18705 | 44.91 | 24.11 2025 | 53123 |
| Stanton Marshall S. | officer: SVP, Clinical & MD Affair | M-Exempt | 20301 | 18.44 | 24.11 2025 | 65054 |
| Stanton Marshall S. | officer: SVP, Clinical & MD Affair | M-Exempt | 27075 | 11.03 | 24.11 2025 | 71828 |
| Hoff Elizabeth A | director | S-Sale | 4200 | 45.10 | 19.11 2025 | 27189 |
| Horton Amy | officer: VP, Chief Accounting Officer | S-Sale | 6000 | 45.73 | 18.11 2025 | 135380 |
| Davis John E | officer: Chief Commercial Officer | M-Exempt | 6394 | 29.62 | 18.11 2025 | 0 |
| Davis John E | officer: Chief Commercial Officer | S-Sale | 6393 | 44.67 | 18.11 2025 | 198842 |
| Davis John E | officer: Chief Commercial Officer | S-Sale | 6394 | 45.17 | 18.11 2025 | 198842 |
| Davis John E | officer: Chief Commercial Officer | M-Exempt | 6393 | 29.62 | 18.11 2025 | 205235 |
| Davis John E | officer: Chief Commercial Officer | M-Exempt | 6394 | 29.62 | 18.11 2025 | 205236 |
| Holloway Jean F | officer: SVP, General Counsel | M-Exempt | 6394 | 29.62 | 18.11 2025 | 0 |
| Holloway Jean F | officer: SVP, General Counsel | S-Sale | 6394 | 45.17 | 18.11 2025 | 163408 |
| Holloway Jean F | officer: SVP, General Counsel | S-Sale | 6393 | 45.00 | 18.11 2025 | 163408 |
| Holloway Jean F | officer: SVP, General Counsel | M-Exempt | 6393 | 29.62 | 18.11 2025 | 169801 |
| Holloway Jean F | officer: SVP, General Counsel | M-Exempt | 6394 | 29.62 | 18.11 2025 | 169802 |
| Stanton Marshall S. | officer: SVP, Clinical & MD Affair | S-Sale | 4993 | 45.86 | 14.11 2025 | 56641 |
| Holloway Jean F | officer: SVP, General Counsel | S-Sale | 5761 | 45.86 | 14.11 2025 | 163408 |
| Mackin James P | officer: President & CEO | S-Sale | 34210 | 45.86 | 14.11 2025 | 800993 |
| Davis John E | officer: Chief Commercial Officer | S-Sale | 6563 | 45.86 | 14.11 2025 | 198842 |
| Horton Amy | officer: VP, Chief Accounting Officer | S-Sale | 3482 | 45.86 | 14.11 2025 | 141380 |
| Horton Amy | officer: VP, Chief Accounting Officer | S-Sale | 1789 | 44.62 | 12.11 2025 | 144862 |
| Davis John E | officer: Chief Commercial Officer | S-Sale | 3373 | 44.62 | 12.11 2025 | 205405 |
| Mackin James P | officer: President & CEO | S-Sale | 17580 | 44.62 | 12.11 2025 | 835203 |
| Holloway Jean F | officer: SVP, General Counsel | M-Exempt | 10000 | 11.03 | 12.11 2025 | 0 |
| Holloway Jean F | officer: SVP, General Counsel | S-Sale | 10000 | 46.18 | 12.11 2025 | 169169 |
| Holloway Jean F | officer: SVP, General Counsel | S-Sale | 2960 | 44.62 | 12.11 2025 | 169169 |
| Holloway Jean F | officer: SVP, General Counsel | M-Exempt | 10000 | 11.03 | 12.11 2025 | 179169 |
